Proteases Global Market Report 2024

The global proteases market has grown strongly in recent years. It will grow from $3.18 billion in 2023 to $3.4 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth observed in the historical period can be credited to various factors, including industrial applications in food processing, enzyme replacement therapy, heightened demand within the detergent industry, extensive utilization in pharmaceutical manufacturing, a burgeoning recognition of enzyme advantages, and its application in the leather and textile sectors, alongside its role in biofuel production.

The global proteases market is expected to see strong growth in the next few years. It will grow to $4.56 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%. The anticipated growth in the upcoming forecast period can be linked to several key factors, notably the increasing traction for sustainable industrial practices, advancements in therapeutic enzyme development, the rise of personalized medicine, expanded applications in cell culture processes, growing demand for enzymes in waste management, progress in protease inhibitor research, and the adoption of novel therapeutic approaches.

Within this forecast, major trends are expected to encompass technological integration, notable advancements in enzyme engineering, a shift towards biological solutions in agriculture, the prominence of specialty enzymes, the expansion of enzyme replacement therapies, the rise of emerging markets, and an emphasis on collaborations for research and development efforts.

The proteases market's anticipated growth is attributed to an increasing demographic of health-conscious consumers seeking wellness-focused lifestyles, particularly emphasizing environmental and nutritional concerns. These consumers exhibit a strong interest in products containing proteases, aligning with digestive health and weight management goals. A survey by Public Health England in January 2021 highlighted a significant shift in consumer behavior, with a considerable majority motivated to adopt healthier lifestyles due to the COVID-19 pandemic. The rising motivation, especially among adults over 18, signifies a substantial drive towards lifestyle changes, indicating an impending surge in demand for proteases.

An upsurge in the animal feed industry is poised to drive the proteases market's expansion. Proteases, pivotal as enzymatic supplements in animal feed formulations, significantly enhance protein digestion, contributing to optimal nutrient absorption in livestock. This advancement leads to improved feed efficiency and healthier animal growth. Notably, statistics from January 2023, indicating increased feed production in various regions including Latin America, North America, and Oceania, highlight the sector's growth. The remarkable rise, particularly in pet feed production globally, underscores the pivotal role of the animal feed industry in propelling the proteases market.

Product innovation emerges as a central trend reshaping the proteases market landscape, with major industry players focusing on developing cutting-edge products for a competitive edge. For instance, the DSM-Novozymes Feed Enzymes Alliance launched ProAct 360 in September 2021, a second-generation protease tailored for the feed industry. This innovative protease promises heightened feed efficiency, sustainability, and cost-effectiveness. Its specialized attributes, including enhanced consistency and increased amino acid release, signify a substantial leap in the market, catering specifically to animal feed applications.

Major corporations leverage strategic collaborations and partnerships to consolidate their positions in the market. For instance, in January 2023, Selecta Biosciences, a US-based biotechnology company, joined forces with Astellas to advance gene therapy portfolios through the Selecta Biosciences clinic. This structured partnership aimed to license and develop an agreement for IdeXork (Xork), demonstrating the collaborative approach undertaken by businesses to strengthen their market presence and foster growth opportunities.

In May 2022, Vertex Pharmaceuticals, a biopharmaceutical firm headquartered in the United States, completed the acquisition of a set of protease medicines from Catalyst Biosciences Inc for a total of $60 million. This strategic acquisition significantly broadens Vertex's existing product portfolio, particularly in the field of protease medicines, positioning the company for future expansion and development opportunities. Catalyst Biosciences Inc., also based in the US, is a prominent biotechnology company known for its advancements in the field.

Major companies operating in the proteases market report are Advanced Enzymes Technologies Limited, E.l. Du Pont de Nemours & Company, Amano Enzymes Inc., Biocatalysts Limited, Koninklijke DSM NV, Dyadic International Incorporated, Specialty Enzymes & Biotechnologies Company, Associated British Foods Plc., BASF SE, Rossari Biotech Limited, Nagase & Company Limited, Jiangsu Boli Bioproducts Company Limited, Creative Enzymes Inc., Kemin Industries Inc., AB Enzymes GmbH, Lallemand Inc., Novozymes A/S, Chr. Hansen Holdings A/S, International Flavors & Fragrances Inc., Enzyme Development Corporation, Enzyme Solutions Inc., Enzyme Supplies Limited, Genencor International Inc., Kerry Group PLC, Lumis Biotech Pvt. Ltd., Megazyme International Ireland Ltd., Roche Diagnostics GmbH, Sandoz International GmbH, Sunson Industry Group Co. Ltd., The Soufflet Group, Thermo Fisher Scientific Inc., VTR Bio-Tech Co. Ltd. North America was the largest region in the proteases market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the proteases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The primary origins of proteases stem from animals, plants, and microbes. Animal-based proteases derive from animals and include pancreatic trypsin, chymotrypsin, pepsin, and renin. These enzymes are accessible in liquid and powder formats, finding applications across industries like food and beverage, healthcare, animal feed, among others.

This report provides proteases market statistics, including proteases industry global market size, regional shares, competitors with a proteases market share, detailed proteases market segments, market trends and opportunities, and any further data you may need to thrive in the proteases industry. This proteases market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The countries covered in the proteases market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The proteases market consists of sales of glutamic, metalloproteases, cysteine, serine, threonine, and aspartic proteases. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.